Sanne P. Roels

Janssen R&D
Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

A Causal Perspective on "Appropriate Implementation of ICH E9(R1) Addendum Strategies" (Comment on Fleming et al.).

A Causal Perspective on "Appropriate Implementation of ICH E9(R1) Addendum Strategies" (Comment on Fleming et al.).

Journal: Statistics in medicine
Published: September 29, 2025

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The lancet. HIV
Published: March 06, 2025

Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial.

Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial.

Journal: EBioMedicine
Published: September 27, 2024

Conspiracy mentality in autistic and non-autistic individuals.

Conspiracy mentality in autistic and non-autistic individuals.

Journal: Cognitive neuropsychiatry
Published: September 10, 2024

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.

Journal: iScience
Published: June 28, 2024

Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk.

Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk.

Journal: Vaccine
Published: April 02, 2024

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Journal: Nature communications
Published: November 16, 2023

Study protocol for a multi-center stepped-wedge cluster randomized trial to explore the usability and outcomes among young people living with HIV in Kiambu and Kirinyaga counties of Kenya, using an online health portal.

Study protocol for a multi-center stepped-wedge cluster randomized trial to explore the usability and outcomes among young people living with HIV in Kiambu and Kirinyaga counties of Kenya, using an online health portal.

Journal: PLOS digital health
Published: October 02, 2023

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Journal: Research square
Published: July 03, 2023

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Journal: Nature communications
Published: May 16, 2023

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.

Journal: Nature microbiology
Published: June 29, 2022

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.

Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026